Schering-Plough: Drugmaker, Heal Thyself
Schering-Plough: Drugmaker, Heal Thyself It has a potential blockbuster and a savvy new CEO. With federal probers and Claritin’s expired […]
Schering-Plough: Drugmaker, Heal Thyself It has a potential blockbuster and a savvy new CEO. With federal probers and Claritin’s expired […]
Geron’s the Biotech of the Day Geron saw its shares rise $1.72, or 25%, to $8.68 after the company said
Geron’s the Biotech of the Day Geron saw its shares rise $1.72, or 25%, to $8.68 after the company said
India ‘to approve GM potato’ The commercial growing of a genetically modified potato which contains nutrients lacking in the diets
India ‘to approve GM potato’ The commercial growing of a genetically modified potato which contains nutrients lacking in the diets
Genentech’s Next Move Genentech stunned the cancer world last week with news that its Avastin colon cancer drug extended patients’
Genentech’s Next Move Genentech stunned the cancer world last week with news that its Avastin colon cancer drug extended patients’
This Dutchman Is Flying Maverick biotech firm Genzyme is winning big profits from a contrarian strategy: Think small
GM crops ‘good for developing countries’ In a discussion paper out on Tuesday to coincide with a national GM debate
GM crops ‘good for developing countries’ In a discussion paper out on Tuesday to coincide with a national GM debate
Get new actionable insights and updates from BiotechBlog